Subscribe To
Calidi biotherapeutics announces commitment of $25 million in series b funding to advance stem cell-based platforms for the delivery and potentiation of oncolytic viruses to treat cancer
Financing led by Jackson Investment Group (JIG) with participation from Calidi Cure, LLC, a consortium of new and existing investors led by Allan Cama...
June 23, 2023, 9:00 am